Chicago Atlantic Real Estate Finance REFI has emerged as a stable investment in the volatile U.S. cannabis sector, delivering returns even as the market faces turbulence. This strategic resilience is underscored in the latest equity research by Pablo Zuanic of Zuanic and Associates.
Financial Highlights
In the second quarter of 2024, REFI’s loan book grew to $382 million, achieving an 8% compound annual growth rate over 24 months. Despite broader market downturns, REFI’s stock exhibited minimal decline, contrasting sharply with the 13.4% drop in the MSOS ETF, demonstrating its robust market position.
Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter here. If you're serious about the business, you can't afford to miss out.
Dividends And Returns
REFI has maintained a consistent dividend payout, with the annualized yield standing at 13.6%, significantly outpacing 10-year Treasury rates. “REFI's dividend strategy reflects its robust approach to value return amidst market volatilities,” Zuanic said.
Read Also: Harris Vs. Trump: Will Cannabis Rescheduling Survive Biden’s Exit? Analyst On Potential GOP Victory
Comparative Analysis
Compared to peers, REFI commands a 7% premium to book value, justified by its superior growth and stable dividends. The portfolio’s yield to maturity of 18.7% further solidifies its attractive position relative to other mortgage REITs, especially those outside the cannabis sector.
Investment Outlook
Zuanic endorses an ‘Overweight’ stance on REFI, citing potential growth driven by anticipated regulatory changes and expansion within the U.S. cannabis industry. He projects a conservative 10% annual growth in the loan book and anticipates dividend increases, reinforcing REFI's appeal as a high-yield, low-volatility investment.
Zuanic concluded that REFI emerges as a prudent choice for investors seeking stability and consistent returns in the cannabis finance sector, backed by strategic management and solid financial fundamentals.
Read Next: Brick-And-Mortar Investments Build Cash Flow And 11% Price Uptick For This Cannabis Stock
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Click on the image for more info.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry?
Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9.
Get your tickets now before prices surge by following this link.